Medications for Hypovolemia

11 results

  • Albumin (human) (albumin human)

    (Albumin Human)
    Octapharma Pharmazeutika Produktionsgesellschaft m.b.H.
    Usage: Albumin (Human) 5% is indicated for the emergency treatment of hypovolemia, particularly when hydration is inadequate, and for critically ill patients with hypoalbuminemia. It also aids in maintaining cardiovascular function after paracentesis due to cirrhotic ascites.

  • Albumin (human) (albumin human)

    (Albumin Human)
    Octapharma Pharmazeutika Produktionsgesellschaft m.b.H.
    Usage: ALBUMIN (HUMAN) 20% is indicated for treating hypovolemia, hypoalbuminemia in critically ill patients, preventing central volume depletion after paracentesis, managing severe ovarian hyperstimulation syndrome, aiding fluid management in adult respiratory distress syndrome, treating edema in acute nephrosis, and addressing hyperbilirubinemia in hemolytic disease of the newborn.

  • Albumin (human) (albumin human)

    (Albumin Human)
    Octapharma Pharmazeutika Produktionsgesellschaft m.b.H.
    Usage: ALBUMIN (HUMAN) 25% is indicated for treating hypovolemia, hypoalbuminemia in critically ill or active bleeding patients, maintaining cardiovascular function post-paracentesis for cirrhotic ascites, managing severe ovarian hyperstimulation syndrome, adjunct treatment for ARDS and acute nephrosis, and treating hyperbilirubinemia in hemolytic disease of the newborn.

  • Albuminex (albumin human)

    (Albumin Human)
    CVS
    Usage: ALBUMINEX 5% is indicated for restoring blood volume in hypovolemia, preventing volume depletion after paracentesis, treating hypoalbuminemia, acute nephrosis, acute respiratory distress syndrome, and as part of priming fluids during cardiopulmonary bypass. It is helpful in both adult and pediatric patients for various volume deficiency conditions.

  • Albutein (albumin (human))

    (ALBUMIN (HUMAN))
    GRIFOLS USA, LLC
    Usage: ALBUTEIN 20% is indicated for restoring blood volume in hypovolemia, treating hypoalbuminemia, aiding in cardiopulmonary bypass, managing acute nephrosis, addressing ovarian hyperstimulation syndrome, treating neonatal hyperbilirubinemia, and assisting in Adult Respiratory Distress Syndrome (ARDS) management. It helps prevent central volume depletion post-paracentesis.

  • Albutein (albumin (human))

    (ALBUMIN (HUMAN))
    GRIFOLS USA, LLC
    Usage: ALBUTEIN 25% is indicated for restoring circulating blood volume in hypovolemia, treating acute nephrosis, hypoalbuminemia, and severe ovarian hyperstimulation syndrome. It serves as a plasma volume expander in conditions like neonatal hyperbilirubinemia and adult respiratory distress syndrome, and aids post-paracentesis fluid management.

  • Albutein (albumin (human))

    (ALBUMIN (HUMAN))
    GRIFOLS USA, LLC
    Usage: ALBUTEIN 5% is indicated for restoring blood volume in hypovolemia, assisting in cardiopulmonary bypass procedures, treating hypoalbuminemia in critically ill patients, maintaining plasma oncotic pressure post-burn, and as a replacement fluid during plasma exchange treatments.

  • Albutein (albumin (human))

    (ALBUMIN (HUMAN))
    GRIFOLS USA, LLC
    Usage: ALBUTEIN 5% is indicated for restoring blood volume in hypovolemia, adjunct use in cardiopulmonary bypass procedures, treating hypoalbuminemia in critically ill or bleeding patients, and as a replacement fluid during plasma exchange. It is also useful in managing shock in renal dialysis patients and post-thermal injury fluid maintenance.

  • Flexbumin

    (Albumin Human)
    Takeda Pharmaceuticals America, Inc.
    Usage: FLEXBUMIN® 25% is indicated for treating hypovolemia, hypoalbuminemia, conditions associated with severe injuries or infections, adult respiratory distress syndrome, nephrosis, assisting in cardiopulmonary bypass surgery, and for infants with severe hemolytic disease of the newborn to manage unconjugated bilirubin. It is not an intravenous nutrient.

  • Flexbumin (albumin human)

    (Albumin human)
    Takeda Pharmaceuticals America, Inc.
    Usage: FLEXBUMIN® 20% (Albumin [Human]) is indicated for hypovolemia, hypoalbuminemia, cardiopulmonary bypass surgery, and hemolytic disease of the newborn (HDN). It treats inadequate albumin levels due to various conditions including burns, infections, and severe injuries, and is used in specific surgical settings for blood dilution.